Hepatitis B Seroprevalence in Risk Groups

Key Points

• Hepatitis B seroprevalence was notably high in identified risk groups, indicating severe public health concerns.
• The analysis found a seroprevalence rate of 10% among injection drug users and 5% among men who have sex with men.
• Observational analysis focused on various risk groups and their exposure to hepatitis B viral infection.
• This highlights the urgent need for better screening and vaccination strategies in vulnerable populations.